Toronto Dominion Bank
VRTX icon

Toronto Dominion Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

Toronto Dominion Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30,000
Closed -$5.08M – 1558
2019
Q3 		$5.08M Buy
+30,000
New +$5.31M 0.01% 639
2018
Q4 		– Sell
-700
Closed -$135K – 1672
2018
Q3 		$135K Buy
+700
New +$125K ﹤0.01% 1094

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Toronto Dominion Bank's VRTX Position: Q1 2026 in Review

Toronto Dominion Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 14% in Q1 2026, selling an estimated $5.98M and leaving 78,472 shares worth $35M. The position accounts for 0.05% of the portfolio, ranked #295.

Toronto Dominion Bank first reported a position in VRTX in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.9M in Q1 2024. 1,688 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Toronto Dominion Bank held 78,472 shares of Vertex Pharmaceuticals worth $35M as of Q1 2026.
  • Toronto Dominion Bank sold 12,816 Vertex Pharmaceuticals shares in Q1 2026, an estimated $5.98M.
  • Vertex Pharmaceuticals made up 0.05% of Toronto Dominion Bank's portfolio in Q1 2026, its #295 holding.
  • Toronto Dominion Bank first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
  • Toronto Dominion Bank's Vertex Pharmaceuticals position peaked at $63.9M in Q1 2024.
  • 1,688 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Toronto Dominion Bank's 13F filing for Q1 2026, filed 15 May 2026.